Mirum Pharmaceuticals, Inc. MIRM Operating Lease Liability Payments - 2026 (Lessee)
Operating Lease Liability Payments - 2026 (Lessee) at other companies
Other financials
Where this comes from
Reported directly by Mirum Pharmaceuticals, Inc. in its filing.
Tagged under the XBRL concept us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueYearThree.
The official record: Mirum Pharmaceuticals, Inc.’s 10-Q, filed May 6, 2026, on SEC EDGAR. View the filing →
Ask your AI about Mirum Pharmaceuticals, Inc.'s operating lease liability payments - 2026 (lessee).
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Mirum Pharmaceuticals, Inc.'s operating lease liability payments - 2026 (lessee)?
- Mirum Pharmaceuticals, Inc. (MIRM) reported operating lease liability payments - 2026 (lessee) of $2.95M in Q1 2026.
- How has Mirum Pharmaceuticals, Inc.'s operating lease liability payments - 2026 (lessee) changed year-over-year?
- Mirum Pharmaceuticals, Inc.'s operating lease liability payments - 2026 (lessee) increased by 26.6% year-over-year, from $2.33M to $2.95M.
- What does operating lease liability payments - 2026 (lessee) mean?
- This represents the specific cash outflow commitment for operating leases scheduled for the calendar year 2026. It allows investors to isolate the impact of real estate and equipment lease obligations on the company's cash flow in a specific future period.